Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01313442 · ClinicalTrials.gov registry record
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
A clinical trial of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT01313442: Recruiting study of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract, sponsored by National Cancer Institute (NCI).
NCT01313442 is a study of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 550 participants, above the 219-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (151% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01313442, a study of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnosed with gastrointestinal cancers. Objectives: \- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with throat, stomach, gallbladder, liver, pancreatic, or colon cancer, and are scheduled to be treated at the National Institutes of Health. Design: * The study will require at least one but no more than four visits to the National Institutes of Health Clinical Center. * Participants will be screened with a physical examination and medical history, and will provide a baseline blood sample for study. * Participants will provide additional blood samples 2 and 4 months after the baseline sample, as well as a final sample at the completion of the treatment protocol. * Participants will provide tumor tissue samples only if they undergo a surgical procedure related to the treatment for their gastrointestinal cancer. * No treatment will be provided as part of this protocol.
Primary Outcome
Collected blood, tumor samples from participants with gastrointestinal (GI) cancers being reviewed by Medical Oncology Branch and to perform immune studies
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2011-03-02 |
What NCT01313442 shows while recruiting
NCT01313442 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, above the 219-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (151% higher).
The record links to 3 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01313442 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01313442 about?
NCT01313442 is a clinical study titled "Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer". Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnos...
What is the current status of trial NCT01313442?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2011-03-02.
What conditions does trial NCT01313442 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer, Cancer of Gastrointestinal Tract, Non-GI Cancers.
Who is sponsoring clinical trial NCT01313442?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01313442 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01313442's enrollment target sits among peer trials
550 7th of 49 higher than 43 of 49 other Gastrointestinal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI